NY Files Charges Against J&J Over Opioids
September 17 2020 - 12:17PM
Dow Jones News
By Stephen Nakrosis
New York State Gov. Andrew Cuomo Thursday said the state has
filed charges against Johnson & Johnson and several of its
subsidiaries, alleging the company fraudulently mischaracterized
the safety and effectiveness of opioid drugs to expand the
market.
The actions are a part of an effort to recover $2 billion in
insurance premium overcharges for New York residents, the state's
Department of Financial Services said in a release.
The department said it has initiated administrative proceedings
against J&J and its subsidiaries Janssen Pharmaceutica, Janssen
Pharmaceuticals, and Ortho-McNeil-Janssen Pharmaceuticals.
The claim alleges that J&J has "had a long-standing and
multi-faceted leading role in originating, supplying, facilitating,
and actively creating a dangerous market for opioids for chronic
pain treatment."
The department alleges J&J violated parts of the state's
insurance law, and that each fraudulent prescription constitutes a
separate violation.
A hearing on the matter is scheduled to begin Jan. 25 of next
year.
J&J didn't immediately respond to a request for comment.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 17, 2020 12:02 ET (16:02 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
